March 12, 2024 - March 14, 2024

Royal Sense IPO Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

Royal Sense IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	0	0	0	1	0
%	0.00	0.00	0.00	100.00	0.00

Royal Sense IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Avoid

Royal Sense IPO Review by Dilip Davda (Avoid)

[Dilip Davda] The company is operating in a highly competitive and fragmented segment. Its financial performance so far is not in line with the asking price. Based on FY24 annualized earnings, the issue appears aggressively priced. There is no harm in skipping this “High Risk/ Low Return” bet. Read detail review...

Royal Sense IPO Peer Comparison

Royal Sense Limited peer comparison with similar listed entities. (As on March 31, 2023)

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share) (Rs)	P/E (x)	RoNW (%)	P/BV Ratio
Royal Sense Limited	1.47	1.47	11.47	33.33	13.00	5.93
Hemant Surgical Industries Ltd	10.26	10.26	30.41	17.34	32.69	5.85
Centenial Surgical Suture Ltd.	2.43	2.43	57.30	42.34	2.85	1.80

Source - All the financial information for listed industry peer mentioned above is sourced from the Annual Reports of the aforesaid companies for the year ended March 31, 2023 and stock exchange data dated May 03, 2023 to compute the corresponding financial ratios. For our Company, we have taken Current Market Price as the issue price of equity share.
Further, P/E Ratio is based on the current market price of the respective scrips.
The EPS, NAV, RoNW and Total Income of our Company are taken as per Restated Financial Statement for the period April 2023 to 30th June 2023.
NAV per share is computed as the closing net worth divided by the closing outstanding number of paid up equity shares as adjusted with the effect of Bonus Issue.
P/E Ratio of the peer company is based on the Annual Report of the company for the year 2023.
RoNW has been computed as net profit after tax divided by closing net worth.
Net worth has been computed in the manner as specifies in Regulation 2(1) (hh) of SEBI (ICDR) Regulations, 2018.
The face value of Equity Shares of our Company is Rs. 10/- per Equity Share and the Issue price is 6 times the face value of equity share.

Royal Sense IPO Review by Members

Royal Sense IPO Reviews, analysis and views by popular members. Read Royal Sense Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Royal Sense IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	0	0
%

Member	Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.